Literature DB >> 29769842

Lyme disease: clinical diagnosis and treatment.

T F Hatchette1,2,3, I Davis1,2, B L Johnston2.   

Abstract

BACKGROUND: Lyme disease is an emerging zoonotic infection in Canada. As the Ixodes tick expands its range, more Canadians will be exposed to Borrelia burgdorferi, the bacterium that causes Lyme disease.
OBJECTIVE: To review the clinical diagnosis and treatment of Lyme disease for front-line clinicians.
METHODS: A literature search using PubMed and restricted to articles published in English between 1977 and 2014.
RESULTS: Individuals in Lyme-endemic areas are at greatest risk, but not all tick bites transmit Lyme disease. The diagnosis is predominantly clinical. Patients with Lyme disease may present with early disease that is characterized by a "bull's eye rash", fever and myalgias or with early disseminated disease that can manifest with arthralgias, cardiac conduction abnormalities or neurologic symptoms. Late Lyme disease in North America typically manifests with oligoarticular arthritis but can present with a subacute encephalopathy. Antibiotic treatment is effective against Lyme disease and works best when given early in the infection. Prophylaxis with doxycyline may be indicated in certain circumstances. While a minority of patients may have persistent symptoms, evidence does not demonstrate that prolonged courses of antibiotics improve outcome.
CONCLUSION: Clinicians need to be aware of the signs and symptoms of Lyme disease. Knowing the regions where Borrelia infection is endemic in North America is important for recognizing patients at risk and informing the need for treatment.

Entities:  

Year:  2014        PMID: 29769842      PMCID: PMC5864449          DOI: 10.14745/ccdr.v40i11a01

Source DB:  PubMed          Journal:  Can Commun Dis Rep        ISSN: 1188-4169


  92 in total

Review 1.  Lyme neuroborreliosis: infection, immunity, and inflammation.

Authors:  Andrew R Pachner; Israel Steiner
Journal:  Lancet Neurol       Date:  2007-06       Impact factor: 44.182

2.  Clinical characteristics and treatment outcome of early Lyme disease in patients with microbiologically confirmed erythema migrans.

Authors:  Robert P Smith; Robert T Schoen; Daniel W Rahn; Vijay K Sikand; John Nowakowski; Dennis L Parenti; Mary S Holman; David H Persing; Allen C Steere
Journal:  Ann Intern Med       Date:  2002-03-19       Impact factor: 25.391

3.  Ceftriaxone compared with doxycycline for the treatment of acute disseminated Lyme disease.

Authors:  R J Dattwyler; B J Luft; M J Kunkel; M F Finkel; G P Wormser; T J Rush; E Grunwaldt; W A Agger; M Franklin; D Oswald; L Cockey; D Maladorno
Journal:  N Engl J Med       Date:  1997-07-31       Impact factor: 91.245

4.  Comparison of cefuroxime axetil and doxycycline in the treatment of early Lyme disease.

Authors:  R B Nadelman; S W Luger; E Frank; M Wisniewski; J J Collins; G P Wormser
Journal:  Ann Intern Med       Date:  1992-08-15       Impact factor: 25.391

5.  Ceftriaxone therapy of chronic inflammatory arthritis. A double-blind placebo controlled trial.

Authors:  E M Caperton; K L Heim-Duthoy; G R Matzke; P K Peterson; R C Johnson
Journal:  Arch Intern Med       Date:  1990-08

6.  Chronic neurologic manifestations of Lyme disease.

Authors:  E L Logigian; R F Kaplan; A C Steere
Journal:  N Engl J Med       Date:  1990-11-22       Impact factor: 91.245

7.  Lyme borreliosis in Bell's palsy. Long Island Neuroborreliosis Collaborative Study Group.

Authors:  J J Halperin; M Golightly
Journal:  Neurology       Date:  1992-07       Impact factor: 9.910

8.  Prospective study on the incidence of infection by Borrelia burgdorferi sensu lato after a tick bite in a highly endemic area of Switzerland.

Authors:  Delphine Huegli; Jacqueline Moret; Olivier Rais; Yves Moosmann; Philippe Erard; Raffaele Malinverni; Lise Gern
Journal:  Ticks Tick Borne Dis       Date:  2011-07-28       Impact factor: 3.744

9.  Functional outcomes in patients with Borrelia burgdorferi reinfection.

Authors:  Tyler M Jares; Michelle A Mathiason; Todd J Kowalski
Journal:  Ticks Tick Borne Dis       Date:  2013-11-09       Impact factor: 3.744

10.  The clinical evolution of Lyme arthritis.

Authors:  A C Steere; R T Schoen; E Taylor
Journal:  Ann Intern Med       Date:  1987-11       Impact factor: 25.391

View more
  12 in total

1.  Performance of a Modified Two-Tiered Testing Enzyme Immunoassay Algorithm for Serologic Diagnosis of Lyme Disease in Nova Scotia.

Authors:  Ian R C Davis; Shelly A McNeil; Wanda Allen; Donna MacKinnon-Cameron; L Robbin Lindsay; Katarina Bernat; Antonia Dibernardo; Jason J LeBlanc; Todd F Hatchette
Journal:  J Clin Microbiol       Date:  2020-06-24       Impact factor: 5.948

2.  Citizen science: Exploring its application as a tool for prodromic surveillance of vector-borne disease.

Authors:  D Hines; S L Sibbald
Journal:  Can Commun Dis Rep       Date:  2015-03-05

Review 3.  Occupational Lyme Disease: A Systematic Review and Meta-Analysis.

Authors:  Nicola Magnavita; Ilaria Capitanelli; Olayinka Ilesanmi; Francesco Chirico
Journal:  Diagnostics (Basel)       Date:  2022-01-25

4.  Laboratory diagnostics for Lyme disease.

Authors:  L R Lindsay; K Bernat; A Dibernardo
Journal:  Can Commun Dis Rep       Date:  2014-05-29

5.  The peptidoglycan-associated protein NapA plays an important role in the envelope integrity and in the pathogenesis of the lyme disease spirochete.

Authors:  Marisela M Davis; Aaron M Brock; Tanner G DeHart; Brittany P Boribong; Katherine Lee; Mecaila E McClune; Yunjie Chang; Nicholas Cramer; Jun Liu; Caroline N Jones; Brandon L Jutras
Journal:  PLoS Pathog       Date:  2021-05-13       Impact factor: 6.823

6.  Clinical manifestations of reported Lyme disease cases in Ontario, Canada: 2005-2014.

Authors:  Karen O Johnson; Mark P Nelder; Curtis Russell; Ye Li; Tina Badiani; Beate Sander; Douglas Sider; Samir N Patel
Journal:  PLoS One       Date:  2018-06-01       Impact factor: 3.240

7.  A Case of Disseminated Lyme Disease Presenting as Chronic Urticaria.

Authors:  Mary Michael; Tamara Gmitter
Journal:  Cureus       Date:  2019-09-09

8.  Surveillance for Lyme disease in Canada, 2009 to 2012.

Authors:  N H Ogden; J K Koffi; L R Lindsay; S Fleming; D C Mombourquette; C Sanford; J Badcock; R R Gad; N Jain-Sheehan; S Moore; C Russell; L Hobbs; R Baydack; S Graham-Derham; L Lachance; K Simmonds; A N Scott
Journal:  Can Commun Dis Rep       Date:  2015-06-04

Review 9.  Lyme Disease Biosensors: A Potential Solution to a Diagnostic Dilemma.

Authors:  Connor Flynn; Anna Ignaszak
Journal:  Biosensors (Basel)       Date:  2020-09-28

10.  Surveillance for Lyme disease in Canada: 2009-2015.

Authors:  S Gasmi; N H Ogden; L R Lindsay; S Burns; S Fleming; J Badcock; S Hanan; C Gaulin; M A Leblanc; C Russell; M Nelder; L Hobbs; S Graham-Derham; L Lachance; A N Scott; E Galanis; J K Koffi
Journal:  Can Commun Dis Rep       Date:  2017-10-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.